--- title: "Reverse Mergers: Planning and Executing a path to Public Capital" description: "Reverse Mergers: Planning and Executing a path to Public Capital - Discover the intricacies of reverse mergers and gain valuable insights into taking your company public through this dynamic financial strategy." image: https://www.lsxleaders.com/hubfs/Reverse%20Mergers%20Planning%20and%20Executing%20a%20Path%20to%20Public%202%20(2).png --- [![LSX The Network for Life Science Executive Leaders](https://www.lsxleaders.com/hubfs/lsx%20f.jpg "LSX The Network for Life Science Executive Leaders")](https://www.lsxleaders.com/) --- ![Reverse Mergers Planning and Executing a Path to Public 2 (2)](https://www.lsxleaders.com/hs-fs/hubfs/Reverse%20Mergers%20Planning%20and%20Executing%20a%20Path%20to%20Public%202%20(2).png?width=847&height=476&name=Reverse%20Mergers%20Planning%20and%20Executing%20a%20Path%20to%20Public%202%20(2).png) # Reverse Mergers: Planning and Executing a Path to Public Capital --- Thursday 30th November 2023 3:00 PM GMT A panel discussion with: - **Michael Cunniffe**, Managing Director, **Danforth Advisors** - **Alan Selby**, Managing Director, **Stifel Financial Corp.** - **David Stewar**t, Partner & Chair of London Capital Markets,** Latham & Watkins** - **Luke Marshall**, Sales Director,** DFIN** Discover the intricacies of reverse mergers and gain valuable insights into taking your company public through this dynamic financial strategy. Our expert speakers will delve into key topics, including: - **Identifying Public Companies for Reverse Mergers:** Discuss the companies involved in these transactions. Who makes a good candidate to merge with, ensuring a seamless transition to the public market. - **Completing a Reverse Merger Transaction on US Capital Markets:** Step-by-step process, from due diligence to regulatory compliance, for a successful reverse merger. - **Operational Impact of a Reverse Merger:** Understand how a reverse merger can affect your day-to-day operations, corporate structure, and life after the transaction. - **Considerations for Foreign Companies:** Explore the unique challenges and opportunities foreign companies face when embarking on a reverse merger journey. Don't miss this opportunity to gain a comprehensive understanding of reverse mergers and the potential they hold for your company's financial future. Join us and learn from industry experts.   Watch Now   **In partnership with** --- [![DFIN Logo](https://www.lsxleaders.com/hs-fs/hubfs/Events/WorldCongress/DFIN%20Logo.png?width=300&height=150&name=DFIN%20Logo.png)](https://www.dfinsolutions.com/en-gb?utm_source=google&utm_medium=Search-Paid&utm_offer=Product-Push&utm_touch=dfin-sfdc-NA_Google_Search-Paid&utm_campaign=brand_general_uk&sfcampid=7013b000001f5lMAAQ&utm_content=brand_search-paid&utm_custom1=expanded_text_ad&utm_custom2=general&gclid=Cj0KCQjwy4KqBhD0ARIsAEbCt6jRwFBj3dgngsNvk206jYDTqZ-qu5ZEDxlupM9robr5Qk7-2u7RET0aAtI6EALw_wcB)     ##### ABOUT [LSX](https://www.lsxleaders.com/) is the Life Science eXecutive partnering community.   We connect biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses. ##### EVENTS [Female Founders](https://www.lsxleaders.com/female-founders) [Inv€$tival Showcase](https://www.lsxleaders.com/investival-showcase) [European Lifestars Awards](https://www.lsxleaders.com/lifestars-awards) [LSX Nordic Congress](https://www.lsxleaders.com/lsx-nordic-congress) [LSX USA Congress](https://www.lsxleaders.com/lsx-usa-congress) [LSX World Congress](https://www.lsxleaders.com/lsx-world-congress) [RNA Leaders Europe](https://www.lsxleaders.com/rna-leaders-world-congress) [RNA Leaders USA](https://www.lsxleaders.com/rna-leaders-usa-congress) [The $yndicate](https://www.lsxleaders.com/syndicate-investment) [Workforce Wellbeing](https://www.lsxleaders.com/workforce-wellbeing-congress) ##### CONNECT [Message us](https://www.lsxleaders.com/contact-us) [Home](https://www.lsxleaders.com/) [LSX](https://www.lsxleaders.com/) Informa Connect, 240 Blackfriars Road, London SE1 8BF, United Kingdom   [![Twitter](https://cdn2.hubspot.net/hub/459002/hubfs/biotech_and_Money/Biotech-twitter.png?width=23&height=24&name=Biotech-twitter.png "Twitter")](https://twitter.com/LSXLeaders)    [![Facebook](https://www.lsxleaders.com/hs-fs/hubfs/fbook%20option%203.png?width=24&height=24&name=fbook%20option%203.png "Facebook")](https://facebook.com/LSXLeaders)    [![Youtube](https://cdn2.hubspot.net/hub/459002/hubfs/biotech_and_Money/Biotech-youtube.png?width=23&height=24&name=Biotech-youtube.png "Youtube")](https://www.youtube.com/channel/UCBjBilvMaUhkgWLjQ95NIQg)    [![Linkedin](https://cdn2.hubspot.net/hub/459002/hubfs/biotech_and_Money/Biotech-Linkedin.png?width=23&height=24&name=Biotech-Linkedin.png "Linkedin")](https://www.linkedin.com/company/lsx-leaders/)   [![Net Zero Website Logo](https://tree-nation.com/images/tracking/label-co2-website-black-en.png) ](https://tree-nation.com/profile/impact/lsx-ltd#co2) [contact](https://www.lsxleaders.com/contact-us) | [privacy policy](https://www.lsxleaders.com/privacy-policy) | [good conduct policy](https://www.lsxleaders.com/good-conduct-policy) | [anti-slavery policy](https://www.lsxleaders.com/anti-slavery-policy) | [anti-money laundering & financial crime policy](https://www.lsxleaders.com/anti-money-laundering-financial-crime-policy) | [diversity & inclusion policy](https://www.lsxleaders.com/diversity-inclusion-policy) | [terms & conditions](https://www.lsxleaders.com/terms-conditions) © 2022 all rights reserved by LSX Ltd